Janson Beckett launches competitively-priced peptide treatment

The New Jersey-based company has carved out its name as a leading developer of peptide-based anti-aging formulations, but many of its products, such as the AlphaDerma treatment are priced well over the $100 mark, putting them in a category of their own.

The launch, called High Performance Anti-Aging Sytem, provides consumers with a combination of the company's peptide-based treatments. aiming to give users a 30-day repair and rejuvinate treatment that costs under $80 - a price tag the company claims will beat most peptide-based treatments currently on the market.

The newly launched system includes smaller sized versions of its three, top-selling topical treatments - AlphaDerma CE, OkuSil, and AH3 Facial Skin Prep - that are said to provide an optiumum combination to help fight visible signs of aging.

Each of the three formulations contains 10 per cent Argireline - a powerful peptide that has gained recognition for its claimed effectiveness in diminishing the frequency of muscle movements that help produce facial lines.

For this reason, many companies marketing peptide-base products have done so under the auspices that such products are an alternative to Botox treatment, because they have much the same effect of controlling the muscle areas that cause facial wrinkling.

However, the peptide treatments have the advantage that they are signifcantly cheaper and are not invasive treatments.

Argireline is manufactured by Spanish company Lipotec and is a hexapeptide (a chain of 6 amino acids) attached to the acetic acid residue - Acetyl Hexapeptide.

Acetyl Hexapeptides, a small chain of six amino acids that are attached to the residue of acetic acid is claimed to allow for a full range of conscious facial contractions, whilst enabling the facial muscles to remain relaxed.

The ingredient has previously been used in anti-aging creams, such as the Bio Technologies range, Elements for Men, as well as Aldenine, and looks set to become even more popular following the most recent product launch by London based company, Sezeur.

Obviously, as the demand for the ingredient grows and production is increases, economies of scale are now starting to kick in, turning what was initially a highly expensive and exclusive ingredient into one that is more accessible for consumers.